Cargando…
Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario
Human visceral leishmaniasis (VL) is a severe and potentially fatal parasitic disease if not correctly diagnosed and treated. Brazil is one of the three countries most endemic for VL and, like most countries affected by this disease, has a large budget constraint for the incorporation of new health...
Autores principales: | Freire, Mariana Lourenço, de Souza, Aline, Cota, Gláucia, Rabello, Ana, Machado de Assis, Tália |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544087/ https://www.ncbi.nlm.nih.gov/pubmed/33031382 http://dx.doi.org/10.1371/journal.pntd.0008741 |
Ejemplares similares
-
Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis
por: Freire, Mariana Lourenço, et al.
Publicado: (2019) -
Serology for visceral leishmaniasis: How trusty is the accuracy reported by the manufacturers?
por: Freire, Mariana Lourenço, et al.
Publicado: (2023) -
Evaluation of a new brand of immunochromatographic test for visceral leishmaniasis in Brazil made available from 2018
por: Freire, Mariana Lourenço, et al.
Publicado: (2018) -
Cost-effectiveness of anti-SARS-CoV-2 antibody diagnostic tests in Brazil
por: de Assis, Tália Santana Machado, et al.
Publicado: (2022) -
Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis
por: Brito, Nayara C., et al.
Publicado: (2019)